LIG4 and glioblastoma: TMZ is an important first-line treatment for GBM, but TMZ response depends largely on the promoter methylation status of the DNA repair gene MGMT, which is a DNA repair enzyme that reverses the alkylating effects of TMZ by removing methyl groups from the O6-guanine position on DNA.